Publications Functional and Molecular Imaging

Publications published since 2009 from OUS - Functional and Molecular Imaging (Revheim)

136 publications found

Publications 2021

  1. Arani LS, Zirakchian Zadeh M, Saboury B, Revheim ME, Øestergaard B, Borja AJ, Samadi Samarin D, Mehdizadeh Seraj S, Kalbush E, Ayubcha C, Morris MA, Werner TJ, Abildgaard N, Høilund-Carlsen PF, Alavi A (2021)
    Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18F- sodium fluoride PET/CT
    J Nucl Cardiol
    DOI 10.1007/s12350-020-02446-0, PubMed 33389640
  2. Ayubcha C, Moghbel M, Borja AJ, Newberg A, Werner TJ, Alavi A, Revheim ME (2021)
    Tau Imaging in Head Injury
    PET Clin, 16 (2), 249-260
    DOI 10.1016/j.cpet.2020.12.009, PubMed 33648666
  3. Borja AJ, Hancin EC, Raynor WY, Ayubcha C, Detchou DK, Werner TJ, Revheim ME, Alavi A (2021)
    A Critical Review of PET Tracers Used for Brain Tumor Imaging
    PET Clin, 16 (2), 219-231
    DOI 10.1016/j.cpet.2020.12.004, PubMed 33589386
  4. Fraz MSA, Moe N, Revheim ME, Stavrinou ML, Durheim MT, Nordøy I, Macpherson ME, Aukrust P, Jørgensen SF, Aaløkken TM, Fevang B (2021)
    Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
    Front Immunol, 11, 617985
    DOI 10.3389/fimmu.2020.617985, PubMed 33584710
  5. Hancin EC, Raynor WY, Borja AJ, Werner TJ, Revheim ME, Alavi A (2021)
    Non-18F-FDG/18F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature
    PET Clin, 16 (2), 273-284
    DOI 10.1016/j.cpet.2020.12.005, PubMed 33589388
  6. Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
    Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
    PET Clin, 16 (2), 147-165
    DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661
  7. Lynch C, Reguilon I, Langer DL, Lane D, De P, Wong WL, Mckiddie F, Ross A, Shack L, Win T, Marshall C, Revheim ME, Danckert B, Butler J, Dizdarevic S, Louzado C, Mcgivern C, Hazlett A, Chew C, O'connell M, Harrison S (2021)
    A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study
    Int J Qual Health Care, 33 (1)
    DOI 10.1093/intqhc/mzaa166, PubMed 33306102
  8. Raynor WY, Borja AJ, Hancin EC, Werner TJ, Alavi A, Revheim ME (2021)
    Novel Musculoskeletal and Orthopedic Applications of 18F-Sodium Fluoride PET
    PET Clin, 16 (2), 295-311
    DOI 10.1016/j.cpet.2020.12.006, PubMed 33589389
  9. Revheim ME, Alavi A (2021)
    PET-based Novel Imaging Techniques with Recently Introduced Radiotracers
    PET Clin, 16 (2), xv-xvi
    DOI 10.1016/j.cpet.2021.01.001, PubMed 33648667
  10. Seierstad T, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Revheim ME, Hernes E (2021)
    18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
    PET Clin, 16 (2), 167-176
    DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662

Publications 2020

  1. Aksnes M, Müller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojević V, Bogdanović N, Knapskog AB (2020)
    Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
    J Alzheimers Dis, 77 (2), 831-842
    DOI 10.3233/JAD-200237, PubMed 32741818
  2. Ayubcha C, Raynor WY, Borja AJ, Seraj SM, Rojulpote C, Werner TJ, Revheim ME, Rajapakse CS, Alavi A (2020)
    Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck
    Nucl Med Commun (in press)
    DOI 10.1097/MNM.0000000000001344, PubMed 33306627
  3. Ayubcha C, Revheim ME, Newberg A, Moghbel M, Rojulpote C, Werner TJ, Alavi A (2020)
    A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
    Eur J Nucl Med Mol Imaging, 48 (2), 623-641
    DOI 10.1007/s00259-020-04926-4, PubMed 32696090
  4. Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
    18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
    Am J Nucl Med Mol Imaging, 10 (1), 66-73
    PubMed 32211220
  5. Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
    F-18-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
    Am. J. Nucl. Med. Molec. Imaging, 10 (1), 66-73
  6. Borja AJ, Hancin EC, Zhang V, Koa B, Bhattaru A, Rojulpote C, Detchou DK, Aly M, Kaghazchi F, Gerke O, Patil S, Gonuguntla K, Werner TJ, Revheim ME, Høilund-Carlsen PF, Alavi A (2020)
    Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk
    Nucl Med Commun (in press)
    DOI 10.1097/MNM.0000000000001349, PubMed 33323870
  7. Borja AJ, Hancin EC, Zhang V, Revheim ME, Alavi A (2020)
    Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders
    Eur J Nucl Med Mol Imaging, 47 (11), 2493-2498
    DOI 10.1007/s00259-020-04697-y, PubMed 31982989
  8. Deek M, Lilleby W, Vaage V, Hole KH, DeWeese T, Stensvold A, Tran P, Seierstad T (2020)
    Impact of radiation dose on recurrence in high-risk prostate cancer patients
    Prostate, 80 (15), 1322-1327
    DOI 10.1002/pros.24059, PubMed 33258482
  9. Dueland S, Syversveen T, Solheim JM, Solberg S, Grut H, Bjørnbeth BA, Hagness M, Line PD (2020)
    Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases
    Ann Surg, 271 (2), 212-218
    DOI 10.1097/SLA.0000000000003404, PubMed 31188200
  10. Gaustad JV, Hauge A, Wegner CS, Simonsen TG, Lund KV, Hansem LMK, Rofstad EK (2020)
    DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness
    Cancers (Basel), 12 (7)
    DOI 10.3390/cancers12071979, PubMed 32698525
  11. Hillestad T, Hompland T, Fjeldbo CS, Skingen VE, Salberg UB, Aarnes EK, Nilsen A, Lund KV, Evensen TS, Kristensen GB, Stokke T, Lyng H (2020)
    MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
    Cancer Res, 80 (18), 3993-4003
    DOI 10.1158/0008-5472.CAN-20-0950, PubMed 32606004
  12. Jacewicz M, Günzel K, Rud E, Lauritzen PM, Galtung KF, Hinz S, Magheli A, Baco E (2020)
    Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia
    Urol Oncol (in press)
    DOI 10.1016/j.urolonc.2020.11.009, PubMed 33257219
  13. Johnsrud K, Seierstad T, Russell D, Revheim ME (2020)
    Inter-reader agreement of 18F-FDG PET/CT for the quantification of carotid artery plaque inflammation
    JRSM Cardiovasc Dis, 9, 2048004020980941
    DOI 10.1177/2048004020980941, PubMed 33403110
  14. Kothekar E, Revheim ME, Borja AJ, Hancin EC, Detchou DK, Werner TJ, Shin DB, Gelfand JM, Alavi A (2020)
    Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system
    Am J Nucl Med Mol Imaging, 10 (5), 265-271
    PubMed 33224623
  15. Kothekar E, Yellanki D, Borja AJ, Al-Zaghal A, Werner TJ, Revheim ME, Gerke O, Saboury B, Gholamrezanezad A, Høilund-Carlsen PF, Alavi A (2020)
    18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology
    Nucl Med Commun, 41 (2), 162-168
    DOI 10.1097/MNM.0000000000001127, PubMed 31860525
  16. Løndalen A, Blakkisrud J, Revheim ME, Madsbu UE, Dahle J, Kolstad A, Stokke C (2020)
    FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
    Eur J Nucl Med Mol Imaging
    DOI 10.1007/s00259-020-05098-x, PubMed 33196921
  17. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2020)
    DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
    Radiat Oncol, 15 (1), 79
    DOI 10.1186/s13014-020-01526-2, PubMed 32293487
  18. Mayer M, Borja AJ, Hancin EC, Auslander T, Revheim ME, Moghbel MC, Werner TJ, Alavi A, Rajapakse CS (2020)
    Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
    Front Physiol, 11, 511391
    DOI 10.3389/fphys.2020.511391, PubMed 33192540
  19. Ottosson F, Baco E, Lauritzen PM, Rud E (2020)
    The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer
    Eur Radiol
    DOI 10.1007/s00330-020-07363-x, PubMed 33141299
  20. Paydary K, Revheim ME, Emamzadehfard S, Gholami S, Pourhassan S, Werner TJ, Høilund-Carlsen PF, Alavi A (2020)
    Quantitative thoracic aorta calcification assessment by 18F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age
    Eur Radiol, 31 (2), 785-794
    DOI 10.1007/s00330-020-07133-9, PubMed 32870396
  21. Pourhassan Shamchi S, Zirakchian Zadeh M, Østergaard B, Kim J, Raynor WY, Khosravi M, Taghvaei R, Nielsen AL, Gerke O, Werner TJ, Holdgaard P, Abildgaard N, Revheim ME, Høilund-Carlsen PF, Alavi A (2020)
    Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
    Nucl Med Commun, 41 (3), 288-293
    DOI 10.1097/MNM.0000000000001144, PubMed 31895757
  22. Rogne AG, Müller EG, Udnaes E, Sigurdardottir S, Raudeberg R, Connelly JP, Revheim ME, Hassel B, Dahlberg D (2020)
    β-Amyloid may accumulate in the human brain after focal bacterial infection: An 18 F-flutemetamol positron emission tomography study
    Eur J Neurol, 28 (3), 877-883
    DOI 10.1111/ene.14622, PubMed 33131195
  23. Ryg U, Lilleby W, Hole KH, Lund-Iversen M, Switlyk MD (2020)
    Local Recurrence of Prostate Cancer to the Intersphincteric Space: A Case Report
    Urology, 140, 18-21
    DOI 10.1016/j.urology.2020.03.009, PubMed 32199872
  24. Seraj SM, Raynor WY, Revheim ME, Al-Zaghal A, Zadeh MZ, Arani LS, Rojulpote C, Werner TJ, Gerke O, Høilund-Carlsen PF, Baker JF, Alavi A, Hunt SJ (2020)
    Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients
    Ann Nucl Med, 34 (6), 424-431
    DOI 10.1007/s12149-020-01463-w, PubMed 32277422
  25. Zadeh MZ, Raynor WY, Ostergaard B, Hess S, Yellanki DP, Ayubcha C, Seraj SM, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang HM, Revheim ME, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2020)
    Correlation of whole-bone marrow dual-time-point F-18-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
    Am. J. Nucl. Med. Molec. Imaging, 10 (5), 257-264
  26. Zadeh MZ, Seraj SM, Østergaard B, Mimms S, Raynor WY, Aly M, Borja AJ, Arani LS, Gerke O, Werner TJ, Zhuang H, Revheim ME, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
    Prognostic significance of 18F-sodium fluoride in newly diagnosed multiple myeloma patients
    Am J Nucl Med Mol Imaging, 10 (4), 151-160
    PubMed 32929393
  27. Zhang V, Borja AJ, Rojulpote C, Padmanabhan S, Patil S, Gonuguntla K, Revheim ME, Werner TJ, Høilund-Carlsen PF, Alavi A (2020)
    Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects
    Am J Nucl Med Mol Imaging, 10 (2), 119-126
    PubMed 32419980
  28. Zhang V, Koa B, Borja AJ, Padmanhabhan S, Bhattaru A, Raynor WY, Rojulpote C, Seraj SM, Werner TJ, Rajapakse C, Alavi A, Revheim ME (2020)
    Diagnosis and Monitoring of Osteoporosis with Total-Body 18F-Sodium Fluoride-PET/CT
    PET Clin, 15 (4), 487-496
    DOI 10.1016/j.cpet.2020.06.011, PubMed 32768370
  29. Zirakchian Zadeh M, Østergaard B, Raynor WY, Revheim ME, Seraj SM, Acosta-Montenegro O, Ayubcha C, Yellanki DP, Al-Zaghal A, Nielsen AL, Constantinescu CM, Gerke O, Werner TJ, Zhuang H, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
    Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy
    Eur J Nucl Med Mol Imaging, 47 (12), 2846-2855
    DOI 10.1007/s00259-020-04768-0, PubMed 32246208
  30. Zirakchian Zadeh M, Raynor WY, Østergaard B, Hess S, Yellanki DP, Ayubcha C, Mehdizadeh Seraj S, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang H, Revheim ME, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
    Correlation of whole-bone marrow dual-time-point 18F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
    Am J Nucl Med Mol Imaging, 10 (5), 257-264
    PubMed 33224622

Publications 2019

  1. Abrahamsson H, Porojnicu AC, Lindstrøm JC, Dueland S, Flatmark K, Hole KH, Seierstad T, Moan J, Redalen KR, Meltzer S, Ree AH (2019)
    High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
    BMC Cancer, 19 (1), 488
    DOI 10.1186/s12885-019-5724-z, PubMed 31122213
  2. Bains SJ, Abrahamsson H, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Meltzer S, Ree AH (2019)
    Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
    Cancer Immunol Immunother, 69 (3), 355-364
    DOI 10.1007/s00262-019-02458-x, PubMed 31893287
  3. Dueland S, Grut H, Syversveen T, Hagness M, Line PD (2019)
    Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis
    Am J Transplant, 20 (2), 530-537
    DOI 10.1111/ajt.15682, PubMed 31674105
  4. Kothekar E, Borja AJ, Gerke O, Werner TJ, Alavi A, Revheim ME (2019)
    Assessing respitatory muscle activity with 18F-FDG-PET/CT in patients with COPD
    Am J Nucl Med Mol Imaging, 9 (6), 309-315
    PubMed 31976160
  5. Lai X, Geier OM, Fleischer T, Garred Ø, Borgen E, Funke SW, Kumar S, Rognes ME, Seierstad T, Børresen-Dale AL, Kristensen VN, Engebraaten O, Köhn-Luque A, Frigessi A (2019)
    Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data
    Cancer Res, 79 (16), 4293-4304
    DOI 10.1158/0008-5472.CAN-18-1804, PubMed 31118201
  6. Lilleby O, Hernes E, Lilleby W (2019)
    Metastatic-directed therapy using PSMA-PET/CT at PSA relapse
    Urol Case Rep, 27, 100992
    DOI 10.1016/j.eucr.2019.100992, PubMed 31453108
  7. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2019)
    Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model
    Acta Oncol, 58 (6), 828-837
    DOI 10.1080/0284186X.2019.1580386, PubMed 30810443
  8. Meltzer S, Bakke KM, Rød KL, Negård A, Flatmark K, Solbakken AM, Kristensen AT, Fuglestad AJ, Kersten C, Dueland S, Seierstad T, Hole KH, Lyckander LG, Larsen FO, Schou JV, Patrick Brown D, Abrahamsson H, Redalen KR, Ree AH (2019)
    Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
    Clin Transl Radiat Oncol, 21, 5-10
    DOI 10.1016/j.ctro.2019.11.006, PubMed 31872084
  9. Mirzaei S, Revheim ME, Raynor W, Zehetner W, Knoll P, Zandieh S, Alavi A (2019)
    64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
    Oncol Ther, 8 (1), 125-131
    DOI 10.1007/s40487-019-00104-1, PubMed 32700066
  10. Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME (2019)
    Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
    PLoS One, 14 (8), e0221365
    DOI 10.1371/journal.pone.0221365, PubMed 31430334
  11. Normann MC, Türzer M, Diep LM, Oldenburg J, Gajdzik B, Solheim O, Rud E (2019)
    Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer
    J Gynecol Oncol, 30 (4), e56
    DOI 10.3802/jgo.2019.30.e56, PubMed 31074244
  12. Rud E, Galtung KF, Lauritzen PM, Baco E, Flatabø T, Sandbæk G (2019)
    Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
    Eur Radiol, 30 (3), 1664-1670
    DOI 10.1007/s00330-019-06521-0, PubMed 31748856
  13. Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
    MRI in the Follow-up of Testicular Cancer: Less is More
    Anticancer Res, 39 (6), 2963-2968
    DOI 10.21873/anticanres.13427, PubMed 31177136
  14. Switlyk MD, Salberg UB, Geier OM, Vlatkovic L, Lilleby W, Lyng H, Seierstad T (2019)
    PTEN Expression in Prostate Cancer: Relationship With Clinicopathologic Features and Multiparametric MRI Findings
    AJR Am J Roentgenol, 212 (6), 1206-1214
    DOI 10.2214/AJR.18.20743, PubMed 30888866

Publications 2018

  1. Bousquet PA, Meltzer S, Sønstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH (2018)
    Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
    Transl Oncol, 12 (1), 76-83
    DOI 10.1016/j.tranon.2018.09.010, PubMed 30273860
  2. de Lange C, Solberg R, Holtedahl JE, Tulipan A, Barlinn J, Trigg W, Wickstrøm T, Saugstad OD, Malinen E, Revheim ME (2018)
    Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs
    Nucl Med Biol, 66, 49-57
    DOI 10.1016/j.nucmedbio.2018.08.004, PubMed 30257223
  3. Halsne T, Müller EG, Spiten AE, Sherwani AG, Gyland Mikalsen LT, Revheim ME, Stokke C (2018)
    The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic 18F-FDG PET/CT
    J Nucl Med Technol, 46 (3), 253-259
    DOI 10.2967/jnmt.117.204586, PubMed 29599401
  4. Hayman J, Hole KH, Seierstad T, Perin J, DeWeese TL, Tran PT, Lilleby W (2018)
    Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
    Urol Oncol, 37 (4), 289.e19-289.e26
    DOI 10.1016/j.urolonc.2018.09.016, PubMed 30446451
  5. Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, Patzke S, Brennhovd B, Seierstad T, Lyng H (2018)
    Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
    Cancer Res, 78 (16), 4774-4785
    DOI 10.1158/0008-5472.CAN-17-3806, PubMed 29945958
  6. Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH (2018)
    Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
    Br J Cancer, 118 (10), 1322-1328
    DOI 10.1038/s41416-018-0085-y, PubMed 29695770
  7. Rud E, Diep L, Baco E (2018)
    A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient
    World J Urol, 36 (4), 629-637
    DOI 10.1007/s00345-018-2171-4, PubMed 29349572
  8. Rud E, Lauritzen P, Baco E (2018)
    Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8
    Eur Urol, 75 (4), e103
    DOI 10.1016/j.eururo.2018.11.047, PubMed 30528223
  9. Simonsen TG, Lund KV, Hompland T, Kristensen GB, Rofstad EK (2018)
    DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma
    Int J Radiat Oncol Biol Phys, 102 (4), 1193-1201
    DOI 10.1016/j.ijrobp.2018.04.035, PubMed 29859790
  10. Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2018)
    Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
    Acta Radiol, 60 (8), 1028-1038
    DOI 10.1177/0284185118810977, PubMed 30379559
  11. Tulipan AJ, Vlatkovic L, Malinen E, Brennhovd B, Hole KH, Lie AK, Ragnum HB, Revheim ME, Seierstad T (2018)
    Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
    Phys Imaging Radiat Oncol, 7, 51-57
    DOI 10.1016/j.phro.2018.09.003, PubMed 33458405

Publications 2017

  1. Ausland L, Revheim ME, Skretting A, Stokke C (2017)
    Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose
    Acta Radiol, 59 (2), 132-139
    DOI 10.1177/0284185117710052, PubMed 28509566
  2. Bakke KM, Hole KH, Dueland S, Grøholt KK, Flatmark K, Ree AH, Seierstad T, Redalen KR (2017)
    Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
    Acta Oncol, 56 (6), 813-818
    DOI 10.1080/0284186X.2017.1287951, PubMed 28464745
  3. Grut H, Dueland S, Line PD, Revheim ME (2017)
    The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
    Eur J Nucl Med Mol Imaging, 45 (2), 218-225
    DOI 10.1007/s00259-017-3843-9, PubMed 29026950
  4. Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim ME (2017)
    18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
    J Nucl Cardiol, 26 (3), 883-893
    DOI 10.1007/s12350-017-1121-7, PubMed 29209949
  5. Kristian A, Holtedahl JE, Torheim T, Futsaether C, Hernes E, Engebraaten O, Mælandsmo GM, Malinen E (2017)
    Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts
    Mol Imaging Biol, 19 (2), 271-279
    DOI 10.1007/s11307-016-0998-x, PubMed 27541026
  6. Lilleby W, Gaudernack G, Brunsvig PF, Vlatkovic L, Schulz M, Mills K, Hole KH, Inderberg EM (2017)
    Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
    Cancer Immunol Immunother, 66 (7), 891-901
    DOI 10.1007/s00262-017-1994-y, PubMed 28391357
  7. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2017)
    Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer
    Acta Oncol, 56 (5), 675-681
    DOI 10.1080/0284186X.2017.1294762, PubMed 28447564
  8. Rusten E, Rekstad BL, Undseth C, Al-Haidari G, Hanekamp B, Hernes E, Hellebust TP, Malinen E, Guren MG (2017)
    Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography
    Radiat Oncol, 12 (1), 147
    DOI 10.1186/s13014-017-0883-z, PubMed 28874205
  9. Torheim T, Malinen E, Hole KH, Lund KV, Indahl UG, Lyng H, Kvaal K, Futsaether CM (2017)
    Autodelineation of cervical cancers using multiparametric magnetic resonance imaging and machine learning
    Acta Oncol, 56 (6), 806-812
    DOI 10.1080/0284186X.2017.1285499, PubMed 28464746

Publications 2016

  1. Baco E, Rud E, Vlatkovic L (2016)
    Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56
    Eur Urol, 70 (2), e55
    DOI 10.1016/j.eururo.2016.01.031, PubMed 26852076
  2. Brænne KR, Flinder LI, Almenning Martiniussen M, Jensen K, Reisse CH, Julsrud L, Martinsen AC (2016)
    A Liver Phantom Study: CT Radiation Dose Reduction and Different Image Reconstruction Algorithms Affect Diagnostic Quality
    J Comput Assist Tomogr, 40 (5), 735-9
    DOI 10.1097/RCT.0000000000000433, PubMed 27224229
  3. Dueland S, Ree AH, Grøholt KK, Saelen MG, Folkvord S, Hole KH, Seierstad T, Larsen SG, Giercksky KE, Wiig JN, Boye K, Flatmark K (2016)
    Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
    Clin Oncol (R Coll Radiol), 28 (8), 532-9
    DOI 10.1016/j.clon.2016.01.014, PubMed 26888115
  4. Flatmark K, Saelen MG, Hole KH, Abrahamsen TW, Fleten KG, Hektoen HH, Redalen KR, Seierstad T, Dueland S, Ree AH (2016)
    Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
    Radiother Oncol, 119 (3), 505-11
    DOI 10.1016/j.radonc.2016.02.020, PubMed 26968754
  5. Goscinski MA, Hole KH, Tønne E, Ryder T, Grøholt KK, Flatmark K (2016)
    Fibromatosis in vertical rectus abdominis myocutaneous flap imitating tumor recurrence after surgery for locally advanced rectal cancer: case report
    World J Surg Oncol, 14, 63
    DOI 10.1186/s12957-016-0818-4, PubMed 26940557
  6. Jonsson M, Ragnum HB, Julin CH, Yeramian A, Clancy T, Frikstad KM, Seierstad T, Stokke T, Matias-Guiu X, Ree AH, Flatmark K, Lyng H (2016)
    Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
    Br J Cancer, 115 (8), 929-939
    DOI 10.1038/bjc.2016.278, PubMed 27599042
  7. Rud E, Baco E (2016)
    Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
    Eur Urol, 70 (5), e136
    DOI 10.1016/j.eururo.2016.04.017, PubMed 27126376
  8. Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, Sandvig K, Llorente A (2016)
    Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
    Eur J Cancer, 70, 122-132
    DOI 10.1016/j.ejca.2016.10.011, PubMed 27914242

Publications 2015

  1. Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O (2015)
    A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
    Eur Urol, 69 (1), 149-56
    DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143
  2. Gaarder M, Seierstad T (2015)
    Measurements of carotid intima media thickness in non-invasive high-frequency ultrasound images: the effect of dynamic range setting
    Cardiovasc Ultrasound, 13, 5
    DOI 10.1186/1476-7120-13-5, PubMed 25628215
  3. Lilleby W, Narrang A, Tafjord G, Vlatkovic L, Russnes KM, Stensvold A, Hole KH, Tran P, Eilertsen K (2015)
    Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
    Radiat Oncol, 10, 232
    DOI 10.1186/s13014-015-0540-3, PubMed 26577452
  4. Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A (2015)
    Identification of prostate cancer biomarkers in urinary exosomes
    Oncotarget, 6 (30), 30357-76
    DOI 10.18632/oncotarget.4851, PubMed 26196085
  5. Redalen KR, Sitter B, Bathen TF, Grøholt KK, Hole KH, Dueland S, Flatmark K, Ree AH, Seierstad T (2015)
    High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer
    Radiother Oncol, 118 (2), 393-8
    DOI 10.1016/j.radonc.2015.11.031, PubMed 26705680
  6. Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM (2015)
    Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
    Eur Urol, 68 (3), 487-96
    DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692
  7. Rud E, Sandbæk G (2015)
    [Guidelines in the wrong direction]
    Tidsskr Nor Laegeforen, 135 (22), 2036
    DOI 10.4045/tidsskr.15.1009, PubMed 26627289
  8. Seierstad T, Hole KH, Grøholt KK, Dueland S, Ree AH, Flatmark K, Redalen KR (2015)
    MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer
    Br J Radiol, 88 (1051), 20150097
    DOI 10.1259/bjr.20150097, PubMed 25899892
  9. Skagen K, Johnsrud K, Evensen K, Scott H, Krohg-Sørensen K, Reier-Nilsen F, Revheim ME, Fjeld JG, Skjelland M, Russell D (2015)
    Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients
    Int J Stroke, 10 (5), 730-6
    DOI 10.1111/ijs.12430, PubMed 25588553
  10. Switlyk MD, Kongsgaard U, Skjeldal S, Hald JK, Hole KH, Knutstad K, Zaikova O (2015)
    Prognostic factors in patients with symptomatic spinal metastases and normal neurological function
    Clin Oncol (R Coll Radiol), 27 (4), 213-21
    DOI 10.1016/j.clon.2015.01.002, PubMed 25624156

Publications 2014

  1. Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB (2014)
    Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
    BJU Int, 114 (4), 532-40
    DOI 10.1111/bju.12545, PubMed 24930692
  2. Baco E, Rud E, Ukimura O, Vlatkovic L, Svindland A, Matsugasumi T, Bernhard JC, Rewcastle JC, Eggesbø HB (2014)
    Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer
    Urol Oncol, 32 (8), 1300-7
    DOI 10.1016/j.urolonc.2014.07.014, PubMed 25189687
  3. Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbø HB, Hung AJ, Matsugasumi T, Bernhard JC, Gill IS, Ukimura O (2014)
    Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer
    J Urol, 193 (2), 466-72
    DOI 10.1016/j.juro.2014.08.084, PubMed 25150643
  4. Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
    Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
    Eur Urol, 67 (4), 787-94
    DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973
  5. Bugge AS, Naalsund A, Johnsrud K, Berstad AE, Kongerud J, Lund MB (2014)
    PET-CT in the assessment of lung cancer at Rikshospitalet from 2007-2011
    Tidsskr Nor Laegeforen, 134 (9), 938-44
    DOI 10.4045/tidsskr.12.1512, PubMed 24828720
  6. Gaarder M, Seierstad T, Søreng R, Drolsum A, Begum K, Dormagen JB (2014)
    Standardized cine-loop documentation in renal ultrasound facilitates skill-mix between radiographer and radiologist
    Acta Radiol, 56 (3), 368-73
    DOI 10.1177/0284185114527868, PubMed 24615418
  7. Hagtvedt T, Seierstad T, Lund KV, Løndalen AM, Bogsrud TV, Smith HJ, Geier OM, Holte H, Aaløkken TM (2014)
    Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma
    Acta Radiol, 56 (2), 152-8
    DOI 10.1177/0284185114526087, PubMed 24585944
  8. Hompland T, Lund KV, Ellingsen C, Kristensen GB, Rofstad EK (2014)
    Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma
    Radiother Oncol, 113 (1), 132-8
    DOI 10.1016/j.radonc.2014.09.011, PubMed 25443501
  9. Nilsen LB, Fangberget A, Geier OM, Engebraaten O, Borgen E, Olsen DR, Seierstad T (2014)
    Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis
    J Magn Reson Imaging, 40 (6), 1382-91
    DOI 10.1002/jmri.24502, PubMed 24470360
  10. Ragnum HB, Vlatkovic L, Lie AK, Axcrona K, Julin CH, Frikstad KM, Hole KH, Seierstad T, Lyng H (2014)
    The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
    Br J Cancer, 112 (2), 382-90
    DOI 10.1038/bjc.2014.604, PubMed 25461803
  11. Revheim ME, Haugvik SP, Johnsrud K, Mathisen Ø, Fjeld JG, Skretting A (2014)
    Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases
    Acta Radiol, 56 (4), 397-403
    DOI 10.1177/0284185114529563, PubMed 24682406
  12. Røe OD, Oppegaard PA, Revheim ME, Svindland A (2014)
    Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin
    BMJ Case Rep, 2014
    DOI 10.1136/bcr-2014-206225, PubMed 25391823
  13. Rud E, Baco E, Lien D, Klotz D, Eggesbø HB (2014)
    Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
    AJR Am J Roentgenol, 202 (3), W241-6
    DOI 10.2214/AJR.12.10483, PubMed 24555620
  14. Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
    Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
    BJU Int, 114 (6b), E32-E42
    DOI 10.1111/bju.12637, PubMed 24447606
  15. Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
    Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
    World J Urol, 33 (7), 1015-21
    DOI 10.1007/s00345-014-1362-x, PubMed 25059766
  16. Switlyk MD, Bruland ØS, Skjeldal S, Hald JK, Seierstad T, Zaikova O (2014)
    Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI
    J Bone Oncol, 3 (1), 5-9
    DOI 10.1016/j.jbo.2014.02.003, PubMed 26909292

Publications 2013

  1. Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E (2013)
    Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome
    Radiother Oncol, 107 (1), 117-22
    DOI 10.1016/j.radonc.2012.11.007, PubMed 23333024
  2. Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J (2013)
    Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
    Case Rep Hematol, 2013, 934781
    DOI 10.1155/2013/934781, PubMed 24455338
  3. Hole KH, Larsen SG, Grøholt KK, Giercksky KE, Ree AH (2013)
    Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer
    Radiother Oncol, 107 (2), 178-83
    DOI 10.1016/j.radonc.2013.03.017, PubMed 23602370
  4. Johnsrud K, Skretting A, Naum AG, Bogsrud TV, Bach-Gansmo T (2013)
    Characterization of an asymmetric add-on collimator used with a hand-held gamma probe for radioguided surgery and sentinel node detection: a demonstration of an alternative collimation method
    Clin Physiol Funct Imaging, 33 (6), 478-82
    DOI 10.1111/cpf.12057, PubMed 23758686
  5. Kristian A, Nilsen LB, Røe K, Revheim ME, Engebråten O, Mælandsmo GM, Holm R, Malinen E, Seierstad T (2013)
    Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
    Nucl Med Mol Imaging, 47 (3), 173-80
    DOI 10.1007/s13139-013-0211-y, PubMed 24900104
  6. Kristian A, Revheim ME, Qu H, Mælandsmo GM, Engebråten O, Seierstad T, Malinen E (2013)
    Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts
    Acta Oncol, 52 (7), 1566-72
    DOI 10.3109/0284186X.2013.813634, PubMed 23984812
  7. Ragnum HB, Røe K, Holm R, Vlatkovic L, Nesland JM, Aarnes EK, Ree AH, Flatmark K, Seierstad T, Lilleby W, Lyng H (2013)
    Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
    Int J Radiat Oncol Biol Phys, 87 (4), 753-60
    DOI 10.1016/j.ijrobp.2013.07.023, PubMed 24035332
  8. Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T (2013)
    Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
    Acta Oncol, 53 (1), 143-8
    DOI 10.3109/0284186X.2013.798428, PubMed 23710697
  9. Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
    Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
    Acta Oncol, 52 (4), 776-82
    DOI 10.3109/0284186X.2013.770920, PubMed 23480638
  10. Skretting A, Revheim ME, Knudtsen IS, Johnsrud K, Bogsrud TV (2013)
    An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds
    Acta Radiol, 54 (6), 672-5
    DOI 10.1177/0284185113478007, PubMed 23463858

Publications 2012

  1. Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
    A man with abdominal pain: enough evidence for surgery?
    Clin Chem, 58 (8), 1187-90
    DOI 10.1373/clinchem.2011.167015, PubMed 22843812
  2. de Lange C, Malinen E, Qu H, Johnsrud K, Skretting A, Saugstad OD, Munkeby BH (2012)
    Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs
    Eur J Nucl Med Mol Imaging, 39 (5), 792-9
    DOI 10.1007/s00259-011-2055-y, PubMed 22297457
  3. Hodt A, Stugaard M, Hisdal J, Stranden E, Atar D, Steine K (2012)
    Regional LV deformation in healthy individuals during isovolumetric contraction and ejection phases assessed by 2D speckle tracking echocardiography
    Clin Physiol Funct Imaging, 32 (5), 372-9
    DOI 10.1111/j.1475-097X.2012.01139.x, PubMed 22856344
  4. Hole KH, Axcrona K, Lie AK, Vlatkovic L, Geier OM, Brennhovd B, Knutstad K, Olsen DR, Seierstad T (2012)
    Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
    Eur Radiol, 23 (4), 1158-66
    DOI 10.1007/s00330-012-2669-x, PubMed 23114883
  5. Nilsen LB, Fangberget A, Geier O, Seierstad T (2012)
    Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations
    Eur Radiol, 23 (4), 1027-33
    DOI 10.1007/s00330-012-2687-8, PubMed 23111816
  6. Rud E, Baco E, Eggesbø HB (2012)
    MRI and ultrasound-guided prostate biopsy using soft image fusion
    Anticancer Res, 32 (8), 3383-9
    PubMed 22843919
  7. Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
    Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
    Acta Oncol, 52 (6), 1160-7
    DOI 10.3109/0284186X.2012.728713, PubMed 23198721
  8. Switlyk MD, Hole KH, Skjeldal S, Hald JK, Knutstad K, Seierstad T, Zaikova O (2012)
    MRI and neurological findings in patients with spinal metastases
    Acta Radiol, 53 (10), 1164-72
    DOI 10.1258/ar.2012.120442, PubMed 23047848

Publications 2011

  1. Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E (2011)
    Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance
    Int J Radiat Oncol Biol Phys, 82 (3), e485-92
    DOI 10.1016/j.ijrobp.2011.05.050, PubMed 22014954
  2. Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K (2011)
    Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies
    BJU Int, 110 (2 Pt 2), E69-75
    DOI 10.1111/j.1464-410X.2011.10759.x, PubMed 22093091
  3. Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E (2011)
    Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
    BMC Cancer, 11, 455
    DOI 10.1186/1471-2407-11-455, PubMed 22014070
  4. Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
    Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
    Mol Imaging Biol, 13 (6), 1234-40
    DOI 10.1007/s11307-010-0464-0, PubMed 21161686

Publications 2010

  1. Folkvord S, Flatmark K, Dueland S, de Wijn R, Grøholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH (2010)
    Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling
    Int J Radiat Oncol Biol Phys, 78 (2), 555-62
    DOI 10.1016/j.ijrobp.2010.04.036, PubMed 20675069
  2. Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
    Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
    Lancet Oncol, 11 (5), 459-64
    DOI 10.1016/S1470-2045(10)70058-9, PubMed 20378407
  3. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2010)
    DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
    Acta Oncol, 50 (1), 148-50
    DOI 10.3109/0284186X.2010.516273, PubMed 21110775
  4. Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2010)
    Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
    Clin Oncol (R Coll Radiol), 23 (5), 339-43
    DOI 10.1016/j.clon.2010.11.006, PubMed 21134733

Publications 2009

  1. Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
    Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
    Anticancer Res, 29 (11), 4331-6
    PubMed 20032375
  2. Seierstad T, Hole KH, Saelen E, Ree AH, Flatmark K, Malinen E (2009)
    MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy
    Radiother Oncol, 93 (2), 279-84
    DOI 10.1016/j.radonc.2009.08.046, PubMed 19800704
 
Page visits: 1821